Lundbeck
HLUN-B.CO
#2507
Rank
NZ$9.85 B
Marketcap
$10.30
Share price
-0.93%
Change (1 day)
20.33%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Net assets

Net assets on the balance sheet as of June 2024 : NZ$5.59 Billion

According to Lundbeck 's latest financial reports the company has NZ$5.59 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Lundbeck - Net assets on balance sheet (from 2009 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$NZ$5.16 B9.54%
2022-12-31$NZ$4.71 B15.68%
2021-12-31$NZ$4.07 B4.78%
2020-12-31$NZ$3.88 B4.08%
2019-12-31$NZ$3.73 B14.78%
2018-12-31$NZ$3.25 B17.72%
2017-12-31$NZ$2.76 B39.54%
2016-12-31$NZ$1.98 B5.34%
2015-12-31$NZ$1.88 B-33.29%
2014-12-31$NZ$2.81 B-7.17%
2013-12-31$NZ$3.03 B6.77%
2012-12-31$NZ$2.84 B-0.25%
2011-12-31$NZ$2.85 B10.84%
2010-12-31$NZ$2.57 B10.2%
2009-12-31$NZ$2.33 B-3.94%
2008-12-31$NZ$2.43 B32.4%
2007-12-31$NZ$1.83 B7.81%
2006-12-31$NZ$1.70 B-1.89%
2005-12-31$NZ$1.73 B-13.22%
2004-12-31$NZ$1.99 B